Hinge Health holder plans sale of 257,900 shares

Hinge Health, Inc. (HNGE) received a Rule 144 notice that Bessemer Venture Partners X may sell 257,900 Class A shares of HNGE through Merrill Lynch on or about September 9, 2026.

Available on EDGAR 09/09/2026 - 05:58 PM EDT Accepted by SEC EDGAR 09/09/2026 - 05:57 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) received a Rule 144 notice that Bessemer Venture Partners X may sell 257,900 Class A shares of HNGE through Merrill Lynch on or about September 9, 2026. These shares were acquired on February 4, 2020 in a private placement for cash. Hinge Health, Inc. reports 62,468,721 Class A shares outstanding.

Key Figures

Shares to be sold: 257,900 shares Class A shares outstanding: 62,468,721 shares Acquisition date of shares: February 4, 2020 +1 more

4 metrics

Shares to be sold 257,900 shares Class A shares proposed for sale for Bessemer Venture Partners X under Rule 144

Class A shares outstanding 62,468,721 shares Class A shares of Hinge Health, Inc. outstanding at the time of the notice

Acquisition date of shares February 4, 2020 Date the securities to be sold were acquired in a private placement

Approximate sale date September 9, 2026 Approximate date of the proposed Rule 144 sale

Key Terms

Rule 144, Private Placement, Class A

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Private Placement financial

"Class A | 02/04/2020 | Private Placement | Issuer"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

Class A financial

"Class A | Merrill Lynch One Bryant Park New York NY 10036 | 257900"

Class A denotes a specific group of a company’s shares that carry a particular set of rights—most commonly different voting power or dividend priority compared with other share classes. Think of it like different seats on a bus where some seats let you steer and others only ride: knowing whether a share is Class A tells investors how much influence they have over company decisions and how returns might be distributed, which affects control and value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for HNGE?

It reports that Bessemer Venture Partners X plans a potential sale of 257,900 Class A shares of Hinge Health, Inc. under Rule 144, indicating an intended resale of previously restricted securities through a broker rather than a new share issuance by the company.

How many HNGE shares are covered by this Form 144 notice?

The notice covers a proposed sale of 257,900 Class A shares of Hinge Health, Inc. for the account of Bessemer Venture Partners X, to be executed through Merrill Lynch.

When were the HNGE shares being sold under this Form 144 originally acquired?

The shares were acquired on February 4, 2020 in a private placement transaction with Hinge Health, Inc., with the consideration listed as cash.

How many HNGE Class A shares are outstanding according to this notice?

The notice lists 62,468,721 Class A shares outstanding for Hinge Health, Inc., providing a context for the size of the 257,900-share proposed sale.

On which exchange are the HNGE shares in this Form 144 expected to trade?

The notice indicates the Class A shares are to be sold on the NYSE, with Merrill Lynch identified as the broker handling the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001768640
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET, 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Bessemer Venture Partners X LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	257900	23904751	62468721	09/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	02/04/2020	Private Placement	Issuer			257900	02/04/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Please see attached for securities sold over the last 3 months.
Date of Notice	09/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Augie Wilkinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)